Canadian pharmaceuticals company Valeant Pharmaceuticals International, Inc. (NYSE:VRX) recently went hostile with its bid to acquire California-based pharmaceutical company ISTA Pharmaceuticals Inc. (NASDAQ:ISTA). Valeant Pharma’s offer price stands at $6.50 per share with the entire deal being valued at $327 million which includes an approximately $13 million assumption of ISTA’s debt.
The $6.50 offer price represents a 67% premium over ISTA’s closing share price on December 15, 2011. Valeant … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards